Baseline disease characteristics were similar across treatment groups, with an overall mean (SD) duration of RA of 7.8 (7.7) years and mean (SD) DAS28-CRP of 4.6 (0.42). The gene discussed is CRP; the disease is rheumatoid arthritis.